AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,458,000 | +8.6% | 34,500 | +25.5% | 0.00% | 0.0% |
| Q2 2020 | $2,263,000 | +133.1% | 27,500 | +66.7% | 0.00% | +200.0% |
| Q1 2020 | $971,000 | -53.0% | 16,500 | -17.5% | 0.00% | -50.0% |
| Q4 2019 | $2,067,000 | +210.4% | 20,000 | -39.2% | 0.00% | +100.0% |
| Q3 2019 | $666,000 | -12.0% | 32,900 | +11.9% | 0.00% | 0.0% |
| Q2 2019 | $757,000 | +26.6% | 29,400 | -30.0% | 0.00% | 0.0% |
| Q1 2019 | $598,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |